The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis
Open accessPublished version of a preprint
Abstract
Pancreatic ductal adenocarcinoma (PDA) has a poor prognosis, and new strategies for prevention and treatment are urgently needed. We previously reported that histone H4 acetylation is elevated in pancreatic acinar cells harboring Kras mutations prior to the appearance of premalignant lesions. Because acetyl-CoA abundance regulates global histone acetylation, we hypothesized that altered acetyl-CoA metabolism might contribute to metabolic or epigenetic alterations that promote tumorigenesis. We found that acetyl-CoA abundance is elevated in KRAS-mutant acinar cells and that its use in the mevalonate pathway supports acinar-to-ductal metaplasia (ADM). Pancreas-specific loss of the acetyl-CoA–producing enzyme ATP-citrate lyase (ACLY) accordingly suppresses ADM and tumor formation. In PDA cells, growth factors promote AKT–ACLY signaling and histone acetylation, and both cell proliferation and tumor growth can be suppressed by concurrent BET inhibition and statin treatment. Thus, KRAS-driven metabolic alterations promote acinar cell plasticity and tumor development, and targeting acetyl-CoA–dependent processes exerts anticancer effects. Significance: Pancreatic cancer is among the deadliest of human malignancies. We identify a key role for the metabolic enzyme ACLY, which produces acetyl-CoA, in pancreatic carcinogenesis. The data suggest that acetyl-CoA use for histone acetylation and in the mevalonate pathway facilitates cell plasticity and proliferation, suggesting potential to target these pathways. See related commentary by Halbrook et al., p. 326. This article is highlighted in the In This Issue feature, p. 305
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oncogenic KRas increases the levels of acetyl coenzyme A (CoA) and reactive oxygen species (ROS) before the development of ADM, and inhibiting these phenotypes blocks ADM (19, 20).”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx247 · Cited by 9,849
Super-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662 · cited 2×
“We also tested regulation of H3K27ac at the EGFR super-enhancer (35) using primers spanning the region (Supplementary Figure S6F).”
BackgroundMethodHingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
ATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298
Self-citationEMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Self-citationThe mystery of membrane organization: composition, regulation and roles of lipid rafts
Sezgin, E., Levental, I., Mayor, S., & Eggeling, C. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.16 · Cited by 2,124
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Acetyl-CoA and the regulation of metabolism: mechanisms and consequences
Shi, L., & Tu, B. P. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.02.003 · Cited by 903
Research works printed but not linked: 1
- Mazur, 2015, Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma, Nat Med, 21, 1163, 10.1038/nm.3952 · DOI
Cited by
Sorted by citations
Items 201–300 of 326
Rosario, S. R., Smith, R. J., Patnaik, S. K., Liu, S., Barbi, J. J., & Yendamuri, S. (2022) · Cancer & Metabolism · doi:10.1186/s40170-022-00292-x · Cited by 7
Metabolic control of epigenetic rearrangements in B cell pathophysiology
Calciolari, B., Scarpinello, G., Tubi, L. Q., Piazza, F., & Carrer, A. (2022) · Open Biology · doi:10.1098/rsob.220038 · Cited by 6
Self-citationThe utility of 3D models to study cholesterol in cancer: Insights and future perspectives
du Plessis, T.-L., Abdulla, N., & Kaur, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1156246 · Cited by 7
Bagheri, H., Adeli, O.-A., Heidari-Soureshjani, S., Azadegan-Dehkordi, Z., & Sherwin, C. M. T. (2024) · Current Drug Research Reviews · doi:10.2174/0125899775281869240311043637 · Cited by 6
Diet predisposes to pancreatic cancer through cellular nutrient sensing pathways
Noè, R., & Carrer, A. (2024) · FEBS Letters · doi:10.1002/1873-3468.14959 · Cited by 7
Self-citationUnderstanding the Conundrum of Pancreatic Cancer in the Omics Sciences Era
Nicoletti, A., Paratore, M., Vitale, F., Negri, M., Quero, G., Esposto, G., Mignini, I., Alfieri, S., Gasbarrini, A., Zocco, M. A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147623 · Cited by 8
Role of ATP citrate lyase and its complementary partner on fatty acid synthesis in gastric cancer
Li, C., Liu, W., Liu, Y., Wang, W., & Deng, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-81448-1 · Cited by 6
Xin, R., Shen, B., Jiang, Y., Liu, J., Li, S., Hou, L., Wu, W., Jia, C., Wu, C., Fu, D., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.923026 · Cited by 6
Wang, J., Wu, X., Xu, J., Liao, Y., Deng, M., Wang, X., & Li, J. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101686 · Cited by 6
Franco, A., Duryea, J., & McDonald, O. G. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10116-z · Cited by 5
Sans, M., Chen, Y., Thege, F. I., Dou, R., Min, J., Yip-Schneider, M., Zhang, J., Wu, R., Irajizad, E., Makino, Y., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.14.553002 · Cited by 6
Duttenhefner, J. N., & Reindl, K. M. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.06.004 · Cited by 5
Gutiérrez-Sandoval, R., Gutiérrez-Castro, F., Muñoz-Godoy, N., Rivadeneira, I., Sobarzo, A., Alarcón, L., Dorado, W., Lagos, A., Montenegro, D., Muñoz, Í., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13061299 · Cited by 5
Discovery of Novel Long‐Chain Alkenyl Diacid Derivatives as ACLY Inhibitors
Song, G., Cao, L., Zhang, M., Yang, Y., Ma, J., Xie, Z., Li, J., & Nan, F. (2022) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202200362 · Cited by 5
Mitochondrial lipid metabolism in metastatic breast cancer
Ruidas, B. (2024) · Mitochondrial Communications · doi:10.1016/j.mitoco.2024.07.001 · Cited by 6
Metabolism Drives Carcinogenesis and Maintenance of Pancreatic Tumors
Halbrook, C. J., Nelson, B. S., & Lyssiotis, C. A. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0034 · Cited by 5
Metabolic Reprogramming and Signaling to Chromatin Modifications in Tumorigenesis
Díaz-Hirashi, Z., Gao, T. X., & Verdeguer, F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_12 · Cited by 5
Li, Y., Zuo, C., & Gu, L. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02335-7 · Cited by 5
RAS: Circuitry and therapeutic targeting
Singh, G., Thakur, N., & Kumar, U. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110505 · Cited by 6
EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening
Cappelletto, A., Alfì, E., Volf, N., Vu, T. V. A., Bortolotti, F., Ciucci, G., Vodret, S., Fantuz, M., Perin, M., Colliva, A., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02942-4 · Cited by 5
Self-citationThe carnitine shuttle links mitochondrial metabolism to histone acetylation and lipogenesisPreprint
Izzo, L., Trefely, S., Demetriadou, C., Drummond, J. M., Mizukami, T., Kuprasertkul, N., Farria, A. T., Nguyen, P. T., Reich, L. N., Shaffer, J. D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.24.509197 · Cited by 5
Self-citationPNLIPRP1 Hypermethylation in Exocrine Pancreas Links Type 2 Diabetes and Cholesterol Metabolism
Maurin, L., Marselli, L., Boissel, M., Ning, L., Boutry, R., Fernandes, J., Suleiman, M., Luca, C. D., Leloire, A., Pascat, V., et al. (2024) · Diabetes · doi:10.2337/db24-0215 · Cited by 4
Huang, X., Wen, Z., Cai, H., & Yu, D. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152033 · Cited by 4
Maladaptive role of peridroplet mitochondria during lipophagy disruption in pancreatic cancer
Zhang, Z., Fang, L., Furukawa, H., Huang, A., Kranrod, J. W., Seubert, J. M., Ito, K., & Aoki, S. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152609 · Cited by 4
Lin, Y., Yang, J., Deng, Y., Wang, Y., Xu, D., Liang, F., Lin, Y., Wang, M., & Wang, Y. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70812 · Cited by 4
Ba, Q., Wang, X., Hu, H., & Lu, Y. (2024) · Diagnostics · doi:10.3390/diagnostics14111094 · Cited by 4
Chen, X., Song, F., Xiao, P., Yao, Y., Li, D., Fang, Y., Lv, S., Mou, Y., Li, Y., & Song, X. (2025) · BMC Cancer · doi:10.1186/s12885-025-13820-x · Cited by 4
Tan, W. L., Subha, S. T., Mohtarrudin, N., & Cheah, Y. K. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08421-5 · Cited by 4
ACLY alternative splicing correlates with cancer phenotypes
Supplee, J., Affronti, H. C., Duan, R., Brooks, R. C., Stine, Z. E., Nguyen, P. T., Pinheiro, L. V., Noji, M., Drummond, J. M., Huang, K. W., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107418 · Cited by 4
Self-citationMethodological Approaches for Assessing Metabolomic Changes in Glioblastomas
Nguyen, T. T. T., Shang, E., Westhoff, M., Karpel‐Massler, G., & Siegelin, M. D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2071-7_19 · Cited by 4
A Citrate Synthase Splice Variant Rewires the TCA Cycle to Promote Colorectal Cancer Progression
Cheung, J. C. T., Ng, L. W., Zhu, Z., Chen, B., Li, S., Xu, M., Ding, X., Pu, D., Hu, Y., Ren, Y., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2355 · Cited by 3
Multidimensional effects of genetic mechanisms in cancer occurrence, development and treatment
Wang, X., Shi, X., Liao, S., Su, T., Gu, Y., Zhang, H., & Li, Z. (2026) · Cancer Genetics · doi:10.1016/j.cancergen.2026.03.006 · Cited by 3
Wang, B., Zhao, L., Gao, Z., Luo, J., Zhang, H., Gan, L., Jiang, K., Wang, S., Ye, Y., & Shen, Z. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09322-0 · Cited by 3
Hong, Y.-P., Yan, X., Ding, Q.-Z., & Zhang, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113485 · Cited by 3
Wu, L., Liang, F., Chen, C., Zhang, Y., Huang, H., & Pan, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-99144-z · Cited by 3
Sinha, S., Panda, A. K., das Neves, R. X., Nwosu, Z. C., Xu, K., van Beek, E., Desai, P. P., Sindiri, S., Chempati, S., Remmert, K., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1055 · Cited by 3
Du, P., Liu, L., Hu, T., & An, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.778035 · Cited by 3
The Noncanonical Functions of Metabolites in Tumor Progression
Wu, S., Qi, Y., & Yang, W. (2024) · Metabolites · doi:10.3390/metabo14030171 · Cited by 3
Yu, L., Wen, Y., Xu, X., Hu, Q., Chang, M., Qiang, R., & Hu, Y. (2024) · Organic & Biomolecular Chemistry · doi:10.1039/d4ob01264j · Cited by 3
Lu, J., Li, G. H., Hu, J., & Wang, Z. (2025) · Communications Biology · doi:10.1038/s42003-025-07860-z · Cited by 3
Illuminating histidine phosphorylation in the pancreatic tumor microenvironmentPreprint
Luhtala, N., Lytle, N. K., DelGiorno, K. E., Shi, Y., Naeem, R. F., Hollingsworth, M. A., Kaech, S. M., Wahl, G. M., & Hunter, T. R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.15.508158 · Cited by 3
Chen, A., Yin, K., Cui, Q., Liu, Y., Wan, X., & Yang, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148378 · Cited by 2
Kumari, S., Sahoo, S., Pulipaka, S., Thomas, A., Kuncha, M., & Kotamraju, S. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112320 · Cited by 2
Xiao, Y., Wang, W., Wang, G., Liu, Y., & Gong, J. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-02987-2 · Cited by 2
Lipid signaling networks in pancreatic cancer progression and therapeutic perspectives
Costamagna, A., Milan, G., Santis, M. C. D., Carrer, A., & Martini, M. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.03.004 · Cited by 2
Self-citation[A Review of Metabolic Stress and Development of Pancreatic Cancer].
Li, J., Lei, M., Lei, Q., & Yin, M. (2021) · 四川大学学报:医学版 · doi:10.12182/20210160502 · Cited by 2
Role of ACLY in the development of gastric cancer under hyperglycemic conditions
Sun, K., Ning, J., Jia, K., Fan, X., Li, H., Ma, J., Meng, M., Ma, C., & Wei, L. (2024) · Quantitative Biology · doi:10.1002/qub2.36 · Cited by 2
Miao, J., Chen, B., Zhang, L., Lu, Z., Wang, R., Wang, C., Jiang, X., Shen, Q., Li, Y., Shi, D., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06305-9 · Cited by 2
Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma
McDonnell, D., Afolabi, P. R., Niazi, U. H. K., Wilding, S. A., Griffiths, G. O., Swann, J. R., Byrne, C. D., & Hamady, Z. Z. R. (2025) · Cancers · doi:10.3390/cancers17071150 · Cited by 2
Road Map to Defeat Pancreatic Cancer
Ferguson, L. P., & Tuveson, D. A. (2025) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-060624-044323 · Cited by 2
ACSS2/AATF Drives Soluble FasL‐Mediated CD8 + T Cell Apoptosis in Pancreatic Neuroendocrine Tumors
Dang, Q., Wang, T., Wang, Y., Zeng, Y., Li, B., Pan, X., Li, Z., Fan, G., Jing, D., Xu, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202506883 · Cited by 2
Cholangiocyte derived carcinomas and local microbiota
Arteta, A. A., Milanes‐Yearsley, M., & Cardona-Castro, N. M. (2020) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.826 · Cited by 2
Metabolic Regulation of Lysine Acetylation: Implications in Cancer
Singh, S., Senapati, P., & Kundu, T. K. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_12 · Cited by 2
Huang, H., Zhou, S., Zhao, X., Wang, S., Yu, H., Lan, L., & Li, L. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12378 · Cited by 2
Emerging epigenetic therapies—lysine acetyltransferase inhibitors
Kaypee, S., Singh, S., Swarnkar, S., & Kundu, T. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91367-6.00019-2 · Cited by 2
Glucose-6-phosphate dehydrogenase deficiency accelerates pancreatic acinar-to-ductal metaplasiaPreprint
Radyk, M. D., Nelson, B. S., Halbrook, C. J., Wood, A., Lavoie, B. L., Salvatore, L., Corfas, G., Colacino, J. A., Shah, Y. M., Crawford, H. C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.06.565895 · Cited by 2
Mitochondrial Function and Dysfunction in White Adipocytes and Therapeutic Implications
Wang, F., Huynh, P. M., & An, Y. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230009 · Cited by 10
Sadaf, S., Vasamsetti, S. B., Jamal, I., Johny, E., Kubra, K., Haque, S., Mannan, A. A. S. R., Razani, B., Chaparala, S., Okawa, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.10.681697 · Cited by 4
Karavaeva, I. E., Basse, A. L., Trammell, S. A. J., Hussain, M. F., Markussen, L. K., Havelund, J. F., Isidor, M. S., Richter, H. J., Chubanava, S., Deleye, Y., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.30.724257 · Cited by 2
Reprogramming of cholesterol sensing in epithelial cells supports pancreatic inflammation
Milan, G., Mareninova, O. A., Fantuz, M., Spacci, M., Paoli, C., Pineda, J. A., Noè, R., Calciolari, B., Zoncu, R., Gukovskaya, A. S., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102292 · Cited by 1
Self-citationParrasia, S., Paoli, C., Varanita, T., Brillo, V., Abdel-Salam, M. A. L., Ongaro, A., Honisch, C., Angi, B., Bachmann, M., Bergamin, F., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108150 · Cited by 1
Self-citationISL@mTOMV nanoparticles: a promising approach for VM-targeted therapy in breast cancer
Fu, C., Li, Z., Tang, B., Fan, Z., Luo, Y. K., Yi, X., Shu, B., Liu, Z., Jiang, B., & Li, Y. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04671-0 · Cited by 1
Hao, Y.-J., Hou, M.-X., Zhu, R., & Liu, J. (2020) · Communications in computer and information science · doi:10.1007/978-981-15-8760-3_7 · Cited by 1
Huang, T. H., Ma, Y., Montal, E. D., Suresh, S., Tagore, M. M., Corbin, A. F., Lumaquin, D., Campbell, N. R., Baggiolini, A., Koche, R. P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.16.496450 · Cited by 1
Metabolic Reprogramming by Histone Deacetylase Inhibition Selectively Targets NRF2-activated tumorsPreprint
Karagiannis, D., Wu, W., Li, A. M., Hayashi, M., Chen, X., Yip, M., Mangipudy, V. S., Xu, X., Rivera, F. J. S., Soto‐Feliciano, Y. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.24.538118 · Cited by 1
Fantuz, M., Liebig, J., Fontana, G., Iebba, V., Carbone, C., Lukassen, S., Conrad, C., & Carrer, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.04.600210 · Cited by 1
Self-citationNutriments et cancer : alliés ou ennemis ?
Guillaumond, F., & Vasseur, S. (2020) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2020.09.003 · Cited by 1
Defining Roles of Metabolic Reprogramming in Pancreatic Tumorigenesis and Tumor Maintenance
Nelson, B. S. (2020) · Deep Blue (University of Michigan)
Wei, P., Bott, A. J., Cluntun, A. A., Morgan, J. T., Cunningham, C. N., Schell, J. C., Ouyang, Y., Ficarro, S. B., Marto, J. A., Danial, N. N., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.26.457847
Wei, P., Bott, A. J., Cluntun, A. A., Morgan, J., Cunningham, C. N., Schell, J. C., Ouyang, Y., Ficarro, S. B., Marto, J. A., Danial, N. N., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3979182
(2022) · Molecular Plant-Microbe Interactions · doi:10.1094/mpmi-35-5
Discovery of a ‘Grail-Shaped’ Drug: Ne-ratinib and the Downregulation of Mutant RAS
Dent, P., Poklepovic, A. S., & Booth, L. A. (2019) · EMJ Oncology · doi:10.33590/emjoncol/10314967
Ippolito, L., Comito, G., Parri, M., Iozzo, M., Duatti, A., Virgilio, F. D., Lorito, N., Bacci, M., Pardella, E., Sandrini, G., et al. (2023) · doi:10.1158/0008-5472.c.6513861.v1
Yang, J., Ren, B., Ren, J., Yang, G., Fang, Y., Wang, X., Zhou, F., You, L., & Zhao, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23590629
Yang, J., Ren, B., Ren, J., Yang, G., Fang, Y., Wang, X., Zhou, F., You, L., & Zhao, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23590647
Yang, J., Ren, B., Ren, J., Yang, G., Fang, Y., Wang, X., Zhou, F., You, L., & Zhao, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23590638
Yang, J., Ren, B., Ren, J., Yang, G., Fang, Y., Wang, X., Zhou, F., You, L., & Zhao, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23590641
Yang, J., Ren, B., Ren, J., Yang, G., Fang, Y., Wang, X., Zhou, F., You, L., & Zhao, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23590623
Yang, J., Ren, B., Ren, J., Yang, G., Fang, Y., Wang, X., Zhou, F., You, L., & Zhao, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23590626
Yang, J., Ren, B., Ren, J., Yang, G., Fang, Y., Wang, X., Zhou, F., You, L., & Zhao, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23590632
Yang, J., Ren, B., Ren, J., Yang, G., Fang, Y., Wang, X., Zhou, F., You, L., & Zhao, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23590620
Metabolite-Based Biosignature of Pancreatic Cancer
Aggarwal, A., Sharma, V., Jacob, J., Semwal, A., & Sahni, D. (2024) · Springer eBooks · doi:10.1007/978-981-99-3746-2_16
Correction: Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis
(2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0865
Wang, A., Yang, H., & Zhu, Y. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673367232250102015441
Opposing effects of systemic and pancreas-specific inhibition of BCKDK on pancreatic carcinogenesisPreprint
Noji, M., Demetriadou, C., Landis, M. D., Pennise, J. L., Pinheiro, L. V., Jaccard, A., Chatoff, A. G., Drummond, J. M., Guo, K., Azor, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.10.658925
Self-citationThe relationship between remnant cholesterol and WHO grade of pancreatic neuroendocrine neoplasms
Zhou, H., Wang, Y., Liu, Y., Guo, C., Wang, J., & Chen, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1616523
Gu, S.-J., Liu, X., Zhou, H., & Yang, J. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00615
Ju, Q., Li, X., Wu, Z., Zhang, P., Chen, H., Ji, J., Gao, W., Zheng, Y., Yu, D., & Zhao, Y. (2025) · Environment & Health · doi:10.1021/envhealth.5c00524
Liu, X., Ren, B., Fang, Y., Ren, J., Wang, X., Gu, M., Zhou, F., Xiao, R., Luo, X., You, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26713939
Liu, X., Ren, B., Fang, Y., Ren, J., Wang, X., Gu, M., Zhou, F., Xiao, R., Luo, X., You, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26713936
Liu, X., Ren, B., Fang, Y., Ren, J., Wang, X., Gu, M., Zhou, F., Xiao, R., Luo, X., You, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25720291
Zhang, Q., Tang, Y., Sun, S., Xie, Q., Yao, J., Wang, X., Qian, J., & Li, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26554088
Cappelletto, A., Alfì, E., Volf, N., Vu, T. V. A., Bortolotti, F., Ciucci, G., Vodret, S., Fantuz, M., Perin, M., Colliva, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24971686
Self-citationLiu, X., Ren, B., Fang, Y., Ren, J., Wang, X., Gu, M., Zhou, F., Xiao, R., Luo, X., You, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26713942
Gotvaldová, K., Špačková, J., Novotný, J., Baslarová, K., Ježek, P., Rossmeislová, L., Gojda, J., & Smolková, K. (2024) · Figshare · doi:10.6084/m9.figshare.25485926
Liu, X., Ren, B., Fang, Y., Ren, J., Wang, X., Gu, M., Zhou, F., Xiao, R., Luo, X., You, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25720138
Gotvaldová, K., Špačková, J., Novotný, J., Baslarová, K., Ježek, P., Rossmeislová, L., Gojda, J., & Smolková, K. (2024) · Figshare · doi:10.6084/m9.figshare.25485716
Hu, C., Xin, Z., Sun, X., Hu, Y., Zhang, C., Yan, R., Wang, Y., Lu, M., Huang, J., Du, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22724243
Wang, B., Zhao, L., Gao, Z., Luo, J., Zhang, H., Gan, L., Jiang, K., Wang, S., Ye, Y., & Shen, Z. (2021) · Figshare · doi:10.6084/m9.figshare.14650620
Cappelletto, A., Alfì, E., Volf, N., Vu, T. V. A., Bortolotti, F., Ciucci, G., Vodret, S., Fantuz, M., Perin, M., Colliva, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24971282
Self-citation
Metadata
- Authors
- Carrer, A., Trefely, S., Zhao, S., Campbell, S. L., Norgard, R. J., Schultz, K. C., Sidoli, S., Parris, J. L. D., Affronti, H. C., Sivanand, S., Egolf, S., Sela, Y., Trizzino, M., Gardini, A., Garcia, B. A., Snyder, N. W., Stanger, B. Z., & Wellen, K. E.
- Affiliations
- University of Pennsylvania (US)
- Drexel University (US)
- The Wistar Institute (US)
- Corresponding author
- Wellen, Kathryn E.
- ORCID
- Venue
- Cancer Discovery
- Published
- 2019-03-01
- Volume
- 9
- Issue
- 3
- Pages
- 416-435
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC6643997
- OpenAlex
- W2911157836
- Cited by
- 313
- References
- 76
- Citations by year
- 2026: 23 · 2025: 49 · 2024: 62 · 2023: 47 · 2022: 44 · 2021: 42 · 2020: 31 · 2019: 15
- FWCI
- 10.44
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-09-04)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Pancreatic Cancer Action Network (14-20-25-WELL)
- NIH (R01CA174761, R01CA228339, R03HD092630, GM110174, AI118891, CA196539, 1F31CA217070-01, F99CA222741, 4K00CA212455-03)
- American Diabetes Association (#1-18-PDF-144)
- UPenn Baccalaureate Research Education (R25-GM071745)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- acetyl-CoA metabolism, pancreatic ductal adenocarcinoma, pancreatic carcinogenesis, ATP citrate lyase, histone H4 acetylation, acinar-to-ductal metaplasia, KRAS mutation, mevalonate pathway, Akt signaling, BET inhibition, statins, cellular plasticity, epigenetic regulation, pancreatic acinar cells
- MeSH terms
- Acetyl Coenzyme A, Acetylation, Animals, Female, Histones, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Pancreatic Neoplasms, Protein Processing, Post-Translational, Genes, ras, Signal Transduction, Mice, Knockout, Carcinoma, Pancreatic Ductal, Cell Proliferation, Acinar Cells, Carcinogenesis, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review